Recent data shows positive attitudes for decentralized trials in rare disease patients
November 2020Most participants in our 2020 survey have no concerns about decentralized clinical trial models. What does this mean for pharma?
You can read the full article here.
Sign up for updates
If you’re an industry professional and would like to subscribe to updates from our research team, including our research projects and our Rare Opinion blog, fill in your details below and we’ll add you to our mailing list.